COVID-19 Kiosks: FREE Testing

Translate to Spanish or other 102 languages!

The City of El Paso will begin offering FREE COVID-19 testing using kiosks located in various locations throughout the City beginning, Friday, October 21, 2022. Courtesy image for illustration purposes
The City of El Paso will begin offering FREE COVID-19 testing using kiosks located in various locations throughout the City beginning, Friday, October 21, 2022. Courtesy image for illustration purposes

Mega Doctor News

- Advertisement -

EL PASO, Texas – The City of El Paso will begin offering FREE COVID-19 testing using kiosks located in various locations throughout the City beginning, Friday, October 21, 2022.

Most of the kiosks will be open 24 hours a day, seven (7) days a week. The tests are free for individuals who are symptomatic, have been exposed, or are at high risk, regardless of insurance status.

The TestAndGo© Fully Automated Healthcare Kiosk is sponsored by the City of El Paso in partnership with the Centers for Disease Control and Prevention’s Increasing Community Access to Testing program (CDC ICATT). 

- Advertisement -

KIOSK LOCATIONS

·         Esperanza Acosta Moreno Branch Library

12480 Pebble Hills

Open 24 hours a day, 7 days a week

- Advertisement -

Located on the exterior of the building adjacent to the rear parking lot

·         Arturo “Tury” Benavides Cielo Vista Transit Center

1165 Sunmount

Open 24 hours a day, 7 days a week

Located on the exterior adjacent to other vending machines

·         Al Jefferson Westside Transit Center

7535 Remcon

Open from 4:30 a.m. to 12:30 a.m.

Located on the interior adjacent to other vending machines

·         University of Texas at El Paso (UTEP) 

*Now in operation

3333 N. Mesa

Open 24 hours a day, 7 days a week

Located on UTEP property (cross street is Kern Drive)

Easy-to-Use Self-Testing Kiosk

Residents can register online at https://register.testandgo.com/ or access the registration app by scanning the QR code on the machine. After you register, scan your QR confirmation code at the kiosk and a test kit will be dispensed. Follow the instructions in the kit to perform the test. The test uses a nasal swab to collect the specimen. Once the specimen is collected, drop off your sample in the kiosk’s collection box. Specimens are picked up daily for PCR testing. 

Results 

Test results will be sent via text or email within 48 hours from your test date. For questions about test results, call 800-402-0000 8 a.m. to 5 p.m. Monday through Friday, and 8 a.m. to 12 p.m. on Saturday.

For more information about the various alternative testing sites click here or visit EPStrong.org.

- Advertisement -
- Advertisement -

- Advertisement -

More Articles

Essential Tips to Prevent Norovirus While Traveling This Summer

Norovirus is a group of viruses that cause diarrhea and gastrointestinal illness.

DHR Health Expands Cancer Care Services with Radiation Oncologist, Dr. Jason Shumadine Wolff

DHR Health, one of the largest physician-owned hospitals in the United States and a proud healthcare provider for the Rio Grande Valley since 1997, is delighted to welcome Dr. Jason Shumadine Wolff, to its growing network of specialty care physicians.

Study Reveals Link Between Parent and Child Weight Is Mostly Genetic

The link between parents’ body mass index (BMI) and their children’s BMI in childhood is driven largely by genetic inheritance, rather than by any direct biological effects of parental weight during pregnancy, a new study suggests.

DHR Health Continues to Lead the Way in Treatment of Alzheimer’s Disease for the RGV

Two years after DHR Health announced it was the first hospital south of San Antonio to successfully administer Leqembi, an FDA-approved intravenous treatment for early Alzheimer’s disease, DHR Health continues to expand access to advanced Alzheimer’s care for patients in the Rio Grande Valley being now the only facility doing amyloid PET Scans, a diagnostic test to accurately diagnose Alzheimer’s disease. DHR Health also offers Kisunla, another FDA-approved intravenous treatment for early symptomatic Alzheimer’s disease.
- Advertisement -